Health Insurance (Accredited Pathology Laboratories—Approval) Principles 2017
12Approval in absence of assessment report
Start here
Get a plain-English read of 12
Turn the raw legal text into a practical explanation grounded in Health Insurance (Accredited Pathology Laboratories—Approval) Principles 2017.
12 Approval in absence of assessment report
(1) If no independent body or special adviser has provided an assessment report in relation to premises, the Minister may consider an application for approval under section 23DN of the Act in relation to those premises and otherwise deal with the application taking into account these Principles if: (2) This subsection applies if an application for approval in relation to premises under section 23DN of the Act is made in relation to: not subject to an approval in principle or an approval under section 23DN of the Act held by the applicant for those premises at the time of making the application. (3) In the absence of exceptional circumstances, the Minister must approve in principle an application which relies on this section if the application is supported by a report from an independent body which states: (c) that the independent body is satisfied with a high level of confidence, taking into account the arrangements in relation to the operation of the premises, that: (ii) the premises are, or will be, appropriately staffed with persons to render, and persons to direct, control and supervise, the pathology services to be rendered at the premises; and (iii) the laboratory is, or will be at the relevant time, participating in a quality assurance program of an independent quality assurance body designed to ensure that the laboratory operates in accordance with the accreditation materials applicable to the kinds of pathology services to which approval of the premises would relate; and (d) the kind of pathology services in respect of which the premises should be approved (identified by reference to items in the pathology services table or by reference to groups of items in the pathology services table); and
Note: The independent quality assurance body mentioned in subparagraph (3)(c)(iii) might not be an independent body within the meaning of subsection 5(2).